SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-23-005107
Filing Date
2023-03-30
Accepted
2023-03-30 16:45:53
Documents
81
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K tmb-20221231x10k.htm   iXBRL 10-K 1651622
2 EX-21.1 tmb-20221231xex21d1.htm EX-21.1 3477
3 EX-23.1 tmb-20221231xex23d1.htm EX-23.1 14494
4 EX-31.1 tmb-20221231xex31d1.htm EX-31.1 14309
5 EX-31.2 tmb-20221231xex31d2.htm EX-31.2 14527
6 EX-32.1 tmb-20221231xex32d1.htm EX-32.1 7624
7 EX-32.2 tmb-20221231xex32d2.htm EX-32.2 7596
  Complete submission text file 0001558370-23-005107.txt   6777483

Data Files

Seq Description Document Type Size
8 EX-101.SCH tmb-20221231.xsd EX-101.SCH 50789
9 EX-101.CAL tmb-20221231_cal.xml EX-101.CAL 48643
10 EX-101.DEF tmb-20221231_def.xml EX-101.DEF 175225
11 EX-101.LAB tmb-20221231_lab.xml EX-101.LAB 453567
12 EX-101.PRE tmb-20221231_pre.xml EX-101.PRE 345995
75 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20221231x10k_htm.xml XML 996195
Mailing Address 375 PHEASANT RUN NEWTOWN PA 18940
Business Address 375 PHEASANT RUN NEWTOWN PA 18940 267-759-3681
Onconova Therapeutics, Inc. (Filer) CIK: 0001130598 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36020 | Film No.: 23781332
SIC: 2834 Pharmaceutical Preparations